The Heat Map shows these symbols by color. Each symbol can be clicked to scroll to the symbol details.

BMRN 1.06%
NASDAQ: BMRN $13 Billion Large-Cap. Show More

BMRN Profile

Market Cap 13 Billion
BMRN Description

BioMarin's focus is on rare-disease therapies. Genzyme (now part of Sanofi) markets Aldurazyme through its joint venture with BioMarin, and BioMarin markets Naglazyme, Vimizim, and Brineura independently. BioMarin also markets Kuvan and Palynziq to treat the rare metabolic disorder PKU (in addition to long-standing U.S. rights, BioMarin has reacquired international rights for Kuvan and Palynziq from Merck KGaA). BioMarin has a hemophilia A gene therapy and a treatment for achondroplasia in late-stage clinical trials.

Visit Website

BMRN Earnings

EPS -0.21 P/E Ratio 0.00
Previous Thu, Aug 1, 2019
Latest Wed, Oct 23, 2019 Tomorrow

BMRN Dividend

Yield --
Ex-Date --
Pay Date --
History --

BMRN Charts

52 Week Low $62.88 on Wed, Oct 2, 2019 .
1 Year
Oct 2, 2019
Oct 22, 2018

Symbol Price Day Ξ” YTD Ξ”
BMRN $68.42 -1.06% -19.47%


Suggested Channels
52 Week Highs Dividend Stocks
Symbol Surfing

How can we make Symbol Surfing better?


©2019 Symbol Surfing All Rights Reserved.

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Cookies Policy | Terms Of Service | Privacy Policy